Recurrent ventricular tachycardia after cardiac sympathetic denervation: Prolonged cycle length with improved hemodynamic tolerance and ablation outcomes.
Justin HayaseVeronica DusiDuc DoOlujimi A AjijolaMarmar VaseghiJay M LeeJane YanagawaNir HoftmanSha'Shonda RevelsEric F BuchHouman KhakpourOsamu FujimuraYuliya KrokhalevaCarlos MaciasJulie SorgJean GimaGeraldine PavezNoel G BoyleKalyanam ShivkumarKalyanam ShivkumarPublished in: Journal of cardiovascular electrophysiology (2020)
RFA for recurrent MMVT post-CSD is a reasonable treatment option with intermediate-term clinical success in 50% of patients. Clinical VT cycle length was significantly increased after CSD with associated improvement in mappable, hemodynamically tolerated VT during RFA.
Keyphrases
- radiofrequency ablation
- end stage renal disease
- ejection fraction
- chronic kidney disease
- newly diagnosed
- preterm infants
- prognostic factors
- left ventricular
- peritoneal dialysis
- type diabetes
- adipose tissue
- patient reported outcomes
- metabolic syndrome
- insulin resistance
- atrial fibrillation
- patient reported
- replacement therapy